Fortress Biotech, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number
Fortress Biotech, Inc. (FBIO) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number of 18.90 thousand shares as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber · last filed 2025-11-14
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 18.90K shares.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 18.90K shares.
- 2025-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 18.90K shares.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 18.90K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number as first filed |
|---|---|---|
| 2025-09-30 | 18.90K shares 10-Q · filed 2025-11-14 | |
| 2025-06-30 | 18.90K shares 10-Q · filed 2025-08-14 | |
| 2025-03-31 | 18.90K shares 10-Q · filed 2025-05-15 | |
| 2024-12-31 | 18.90K shares 10-K · filed 2025-03-31 | |
| 2024-09-30 | 18.90K shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 18.90K shares 10-Q · filed 2024-08-13 | |
| 2024-03-31 | 18.90K shares 10-Q · filed 2024-05-15 | |
| 2023-12-31 | 18.90K shares 10-K · filed 2024-03-28 | |
| 2023-09-30 | 40.23K shares 10-Q · filed 2023-11-14 | |
| 2023-06-30 | 603.49K shares 10-Q · filed 2023-08-14 | |
| 2023-03-31 | 603.49K shares 10-Q · filed 2023-05-15 | |
| 2022-12-31 | 650.99K shares 10-K · filed 2023-03-31 | |
| 2022-09-30 | 650.99K shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 705.99K shares 10-Q · filed 2022-08-11 | |
| 2022-03-31 | 705.99K shares 10-Q · filed 2022-05-12 | |
| 2021-12-31 | 1.02M shares 10-K · filed 2022-03-28 | |
| 2021-09-30 | 1.02M shares 10-Q · filed 2021-11-15 | |
| 2017-09-30 | 1.09M shares 10-Q · filed 2017-11-09 | |
| 2017-06-30 | 1.09M shares 10-Q · filed 2017-08-09 | |
| 2017-03-31 | 1.11M shares 10-Q · filed 2017-05-10 | |
| 2016-12-31 | 1.11M shares 10-K · filed 2018-03-16 | 1.11M shares 10-K · filed 2017-03-16 |
| 2016-09-30 | 1.07M shares 10-Q · filed 2016-11-09 | |
| 2016-06-30 | 1.07M shares 10-Q · filed 2016-08-09 | |
| 2016-03-31 | 1.08M shares 10-Q · filed 2016-05-10 | |
| 2015-12-31 | 1.07M shares 10-K · filed 2016-03-15 | |
| 2015-09-30 | 1.63M shares 10-Q · filed 2015-11-09 | |
| 2015-06-30 | 1.75B shares 10-Q · filed 2015-08-10 | |
| 2015-03-31 | 1.68B shares 10-Q · filed 2015-05-11 | |
| 2014-12-31 | 1.73M shares 10-K · filed 2015-03-16 | |
| 2014-09-30 | 1.65B shares 10-Q · filed 2014-11-06 | |
| 2014-06-30 | 1.59B shares 10-Q · filed 2014-08-11 | |
| 2014-03-31 | 1.49B shares 10-Q · filed 2014-05-12 | |
| 2013-12-31 | 2.17M shares 10-K · filed 2014-03-14 | |
| 2013-09-30 | 1.08M shares 10-Q · filed 2013-11-01 | |
| 2013-06-30 | 1.05M shares 10-Q · filed 2013-08-05 | |
| 2013-03-31 | 857.05K shares 10-Q · filed 2013-05-09 | |
| 2012-12-31 | 856.05K shares 10-K · filed 2013-03-18 | |
| 2012-09-30 | 578.02K shares 10-Q · filed 2012-11-14 | |
| 2012-06-30 | 451.36K shares 10-Q · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |